{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T21:52:39Z","timestamp":1794433959262,"version":"4.9.1"},"reference-count":76,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T00:00:00Z","timestamp":1707696000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Aging"],"DOI":"10.1038\/s43587-023-00565-0","type":"journal-article","created":{"date-parts":[[2024,2,12]],"date-time":"2024-02-12T12:02:35Z","timestamp":1707739355000},"page":"247-260","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":309,"title":["Plasma proteomic profiles predict future dementia in healthy adults"],"prefix":"10.1038","volume":"4","author":[{"given":"Yu","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7079-8041","authenticated-orcid":false,"given":"Jia","family":"You","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Shi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu-Yuan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Ru","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3874-0130","authenticated-orcid":false,"given":"Qiang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5987-2258","authenticated-orcid":false,"given":"Jian-Feng","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1118-1743","authenticated-orcid":false,"given":"Wei","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2532-383X","authenticated-orcid":false,"given":"Jin-Tai","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2024,2,12]]},"reference":[{"key":"565_CR1","doi-asserted-by":"publisher","first-page":"1577","DOI":"10.1016\/S0140-6736(20)32205-4","volume":"397","author":"P Scheltens","year":"2021","unstructured":"Scheltens, P. et al. Alzheimer\u2019s disease. Lancet 397, 1577\u20131590 (2021).","journal-title":"Lancet"},{"key":"565_CR2","doi-asserted-by":"publisher","first-page":"1752","DOI":"10.1002\/alz.12802","volume":"19","author":"N Swaddiwudhipong","year":"2023","unstructured":"Swaddiwudhipong, N. et al. Pre-diagnostic cognitive and functional impairment in multiple sporadic neurodegenerative diseases. Alzheimers Dement. 19, 1752\u20131763 (2023).","journal-title":"Alzheimers Dement."},{"key":"565_CR3","doi-asserted-by":"publisher","first-page":"1285","DOI":"10.1016\/S1474-4422(16)30235-6","volume":"15","author":"H Shah","year":"2016","unstructured":"Shah, H. et al. Research priorities to reduce the global burden of dementia by 2025. Lancet Neurol. 15, 1285\u20131294 (2016).","journal-title":"Lancet Neurol."},{"key":"565_CR4","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1016\/S1474-4422(21)00361-6","volume":"21","author":"CE Teunissen","year":"2022","unstructured":"Teunissen, C. E. et al. Blood-based biomarkers for Alzheimer\u2019s disease: towards clinical implementation. Lancet Neurol. 21, 66\u201377 (2022).","journal-title":"Lancet Neurol."},{"key":"565_CR5","doi-asserted-by":"publisher","first-page":"1687","DOI":"10.1002\/alz.12618","volume":"18","author":"H Zetterberg","year":"2022","unstructured":"Zetterberg, H. Biofluid-based biomarkers for Alzheimer\u2019s disease-related pathologies: an update and synthesis of the literature. Alzheimers Dement. 18, 1687\u20131693 (2022).","journal-title":"Alzheimers Dement."},{"key":"565_CR6","doi-asserted-by":"publisher","first-page":"2669","DOI":"10.1002\/alz.12756","volume":"18","author":"O Hansson","year":"2022","unstructured":"Hansson, O. et al. The Alzheimer\u2019s Association appropriate use recommendations for blood biomarkers in Alzheimer\u2019s disease. Alzheimers Dement. 18, 2669\u20132686 (2022).","journal-title":"Alzheimers Dement."},{"key":"565_CR7","doi-asserted-by":"publisher","first-page":"249","DOI":"10.1038\/nature25456","volume":"554","author":"A Nakamura","year":"2018","unstructured":"Nakamura, A. et al. High performance plasma amyloid-beta biomarkers for Alzheimer\u2019s disease. Nature 554, 249\u2013254 (2018).","journal-title":"Nature"},{"key":"565_CR8","doi-asserted-by":"publisher","first-page":"1034","DOI":"10.1038\/s41591-021-01348-z","volume":"27","author":"S Palmqvist","year":"2021","unstructured":"Palmqvist, S. et al. Prediction of future Alzheimer\u2019s disease dementia using plasma phospho-tau combined with other accessible measures. Nat. Med. 27, 1034\u20131042 (2021).","journal-title":"Nat. Med."},{"key":"565_CR9","doi-asserted-by":"publisher","first-page":"e87","DOI":"10.1016\/S2666-7568(20)30061-1","volume":"2","author":"IMW Verberk","year":"2021","unstructured":"Verberk, I. M. W. et al. Serum markers glial fibrillary acidic protein and neurofilament light for prognosis and monitoring in cognitively normal older people: a prospective memory clinic-based cohort study. Lancet Healthy Longev. 2, e87\u2013e95 (2021).","journal-title":"Lancet Healthy Longev."},{"key":"565_CR10","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-019-13901-z","volume":"11","author":"K Kim","year":"2020","unstructured":"Kim, K. et al. Clinically accurate diagnosis of Alzheimer\u2019s disease via multiplexed sensing of core biomarkers in human plasma. Nat. Commun. 11, 119 (2020).","journal-title":"Nat. Commun."},{"key":"565_CR11","doi-asserted-by":"publisher","first-page":"2555","DOI":"10.1038\/s41591-022-02074-w","volume":"28","author":"NJ Ashton","year":"2022","unstructured":"Ashton, N. J. et al. Differential roles of A\u03b242\/40, p-tau231 and p-tau217 for Alzheimer\u2019s trial selection and disease monitoring. Nat. Med. 28, 2555\u20132562 (2022).","journal-title":"Nat. Med."},{"key":"565_CR12","doi-asserted-by":"publisher","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","volume":"19","author":"TK Karikari","year":"2020","unstructured":"Karikari, T. K. et al. Blood phosphorylated tau 181 as a biomarker for Alzheimer\u2019s disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts. Lancet Neurol. 19, 422\u2013433 (2020).","journal-title":"Lancet Neurol."},{"key":"565_CR13","doi-asserted-by":"publisher","first-page":"360","DOI":"10.1001\/jamaneurol.2022.5272","volume":"80","author":"N Mattsson-Carlgren","year":"2023","unstructured":"Mattsson-Carlgren, N. et al. Prediction of longitudinal cognitive decline in preclinical Alzheimer disease using plasma biomarkers. JAMA Neurol. 80, 360\u2013369 (2023).","journal-title":"JAMA Neurol."},{"key":"565_CR14","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1038\/s41582-022-00665-2","volume":"18","author":"TK Karikari","year":"2022","unstructured":"Karikari, T. K. et al. Blood phospho-tau in Alzheimer disease: analysis, interpretation, and clinical utility. Nat. Rev. Neurol. 18, 400\u2013418 (2022).","journal-title":"Nat. Rev. Neurol."},{"key":"565_CR15","doi-asserted-by":"publisher","first-page":"e12018","DOI":"10.1002\/trc2.12018","volume":"6","author":"T Tanaka","year":"2020","unstructured":"Tanaka, T. et al. Plasma proteomic signatures predict dementia and cognitive impairment. Alzheimers Dement. (N Y) 6, e12018 (2020).","journal-title":"Alzheimers Dement. (N Y)"},{"key":"565_CR16","doi-asserted-by":"publisher","first-page":"3042","DOI":"10.1093\/brain\/awl279","volume":"129","author":"A Hye","year":"2006","unstructured":"Hye, A. et al. Proteome-based plasma biomarkers for Alzheimer\u2019s disease. Brain 129, 3042\u20133050 (2006).","journal-title":"Brain"},{"key":"565_CR17","doi-asserted-by":"publisher","first-page":"55","DOI":"10.1186\/s13024-021-00474-z","volume":"16","author":"B Bai","year":"2021","unstructured":"Bai, B. et al. Proteomic landscape of Alzheimer\u2019s disease: novel insights into pathogenesis and biomarker discovery. Mol. Neurodegener. 16, 55 (2021).","journal-title":"Mol. Neurodegener."},{"key":"565_CR18","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1038\/s43587-021-00064-0","volume":"1","author":"KA Walker","year":"2021","unstructured":"Walker, K. A. et al. Large-scale plasma proteomic analysis identifies proteins and pathways associated with dementia risk. Nat. Aging 1, 473\u2013489 (2021).","journal-title":"Nat. Aging"},{"key":"565_CR19","doi-asserted-by":"publisher","first-page":"484","DOI":"10.1016\/S1474-4422(21)00066-1","volume":"20","author":"B Dubois","year":"2021","unstructured":"Dubois, B. et al. Clinical diagnosis of Alzheimer\u2019s disease: recommendations of the International Working Group. Lancet Neurol. 20, 484\u2013496 (2021).","journal-title":"Lancet Neurol."},{"key":"565_CR20","doi-asserted-by":"publisher","first-page":"1220","DOI":"10.1093\/brain\/awaa054","volume":"143","author":"F de Wolf","year":"2020","unstructured":"de Wolf, F. et al. Plasma tau, neurofilament light chain and amyloid-\u03b2 levels and risk of dementia; a population-based cohort study. Brain 143, 1220\u20131232 (2020).","journal-title":"Brain"},{"key":"565_CR21","doi-asserted-by":"publisher","first-page":"6612871","DOI":"10.1155\/2020\/6612871","volume":"2020","author":"W Ma","year":"2020","unstructured":"Ma, W. et al. Elevated levels of serum neurofilament light chain associated with cognitive impairment in vascular dementia. Dis. Markers 2020, 6612871 (2020).","journal-title":"Dis. Markers"},{"key":"565_CR22","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1001\/jamaneurol.2021.3671","volume":"78","author":"AL Benedet","year":"2021","unstructured":"Benedet, A. L. et al. Differences between plasma and cerebrospinal fluid glial fibrillary acidic protein levels across the Alzheimer disease continuum. JAMA Neurol. 78, 1471\u20131483 (2021).","journal-title":"JAMA Neurol."},{"key":"565_CR23","doi-asserted-by":"publisher","first-page":"68","DOI":"10.1186\/s13195-021-00804-9","volume":"13","author":"C Cicognola","year":"2021","unstructured":"Cicognola, C. et al. Plasma glial fibrillary acidic protein detects Alzheimer pathology and predicts future conversion to Alzheimer dementia in patients with mild cognitive impairment. Alzheimers Res. Ther. 13, 68 (2021).","journal-title":"Alzheimers Res. Ther."},{"key":"565_CR24","doi-asserted-by":"publisher","first-page":"e014659","DOI":"10.1161\/JAHA.119.014659","volume":"9","author":"ER McGrath","year":"2020","unstructured":"McGrath, E. R. et al. Growth differentiation factor 15 and NT-proBNP as blood-based markers of vascular brain injury and dementia. J. Am. Heart Assoc. 9, e014659 (2020).","journal-title":"J. Am. Heart Assoc."},{"key":"565_CR25","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1186\/s40478-019-0795-2","volume":"7","author":"CD Whelan","year":"2019","unstructured":"Whelan, C. D. et al. Multiplex proteomics identifies novel CSF and plasma biomarkers of early Alzheimer\u2019s disease. Acta Neuropathol. Commun. 7, 169 (2019).","journal-title":"Acta Neuropathol. Commun."},{"key":"565_CR26","doi-asserted-by":"publisher","first-page":"4575","DOI":"10.3390\/jcm10194575","volume":"10","author":"M Dulewicz","year":"2021","unstructured":"Dulewicz, M., Kulczy\u0144ska-Przybik, A., S\u0142owik, A., Borawska, R. & Mroczko, B. Neurogranin and neuronal pentraxin receptor as synaptic dysfunction biomarkers in Alzheimer\u2019s disease. J. Clin. Med. 10, 4575 (2021).","journal-title":"J. Clin. Med."},{"key":"565_CR27","doi-asserted-by":"publisher","first-page":"90","DOI":"10.1136\/jnnp-2022-329663","volume":"94","author":"A O\u2019Connor","year":"2023","unstructured":"O\u2019Connor, A. et al. Plasma GFAP in presymptomatic and symptomatic familial Alzheimer\u2019s disease: a longitudinal cohort study. J. Neurol. Neurosurg. Psychiatry 94, 90\u201392 (2023).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"565_CR28","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1136\/jnnp-2013-307454","volume":"86","author":"J Kuhle","year":"2015","unstructured":"Kuhle, J. et al. Serum neurofilament light chain is a biomarker of human spinal cord injury severity and outcome. J. Neurol. Neurosurg. Psychiatry 86, 273\u2013279 (2015).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"565_CR29","doi-asserted-by":"publisher","first-page":"882","DOI":"10.1111\/acel.12116","volume":"12","author":"T Fuchs","year":"2013","unstructured":"Fuchs, T. et al. Macrophage inhibitory cytokine-1 is associated with cognitive impairment and predicts cognitive decline \u2013 the Sydney Memory and Aging Study. Aging Cell 12, 882\u2013889 (2013).","journal-title":"Aging Cell"},{"key":"565_CR30","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.3389\/fimmu.2019.01965","volume":"10","author":"H Babu","year":"2019","unstructured":"Babu, H. et al. Systemic inflammation and the increased risk of inflamm-aging and age-associated diseases in people living with HIV on long term suppressive antiretroviral therapy. Front. Immunol. 10, 1965 (2019).","journal-title":"Front. Immunol."},{"key":"565_CR31","doi-asserted-by":"publisher","first-page":"15502","DOI":"10.1073\/pnas.1206446109","volume":"109","author":"JM Castellano","year":"2012","unstructured":"Castellano, J. M. et al. Low-density lipoprotein receptor overexpression enhances the rate of brain-to-blood A\u03b2 clearance in a mouse model of \u03b2-amyloidosis. Proc. Natl Acad. Sci. USA 109, 15502\u201315507 (2012).","journal-title":"Proc. Natl Acad. Sci. USA"},{"key":"565_CR32","doi-asserted-by":"publisher","first-page":"351","DOI":"10.3389\/fncel.2019.00351","volume":"13","author":"W Li","year":"2019","unstructured":"Li, W. et al. Dl-3-n-butylphthalide reduces cognitive impairment induced by chronic cerebral hypoperfusion through GDNF\/GFR\u03b11\/Ret signaling preventing hippocampal neuron apoptosis. Front. Cell Neurosci. 13, 351 (2019).","journal-title":"Front. Cell Neurosci."},{"key":"565_CR33","doi-asserted-by":"publisher","first-page":"659","DOI":"10.1136\/jnnp-2021-328547","volume":"93","author":"P Oeckl","year":"2022","unstructured":"Oeckl, P. et al. Serum GFAP differentiates Alzheimer\u2019s disease from frontotemporal dementia and predicts MCI-to-dementia conversion. J. Neurol. Neurosurg. Psychiatry 93, 659\u2013667 (2022).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"565_CR34","doi-asserted-by":"publisher","first-page":"1069411","DOI":"10.3389\/fneur.2023.1069411","volume":"14","author":"P Kivis\u00e4kk","year":"2023","unstructured":"Kivis\u00e4kk, P. et al. Plasma biomarkers for diagnosis of Alzheimer\u2019s disease and prediction of cognitive decline in individuals with mild cognitive impairment. Front. Neurol. 14, 1069411 (2023).","journal-title":"Front. Neurol."},{"key":"565_CR35","doi-asserted-by":"publisher","first-page":"1020","DOI":"10.1002\/alz.12745","volume":"19","author":"L Beyer","year":"2023","unstructured":"Beyer, L. et al. Amyloid-beta misfolding and GFAP predict risk of clinical Alzheimer\u2019s disease diagnosis within 17 years. Alzheimers Dement. 19, 1020\u20131028 (2023).","journal-title":"Alzheimers Dement."},{"key":"565_CR36","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1002\/alz.12614","volume":"19","author":"H Stocker","year":"2023","unstructured":"Stocker, H. et al. Association of plasma biomarkers, p-tau181, glial fibrillary acidic protein, and neurofilament light, with intermediate and long-term clinical Alzheimer\u2019s disease risk: results from a prospective cohort followed over 17 years. Alzheimers Dement. 19, 25\u201335 (2023).","journal-title":"Alzheimers Dement."},{"key":"565_CR37","doi-asserted-by":"publisher","first-page":"481","DOI":"10.3233\/JAD-180325","volume":"67","author":"P Oeckl","year":"2019","unstructured":"Oeckl, P. et al. Glial fibrillary acidic protein in serum is increased in Alzheimer\u2019s disease and correlates with cognitive impairment. J. Alzheimers Dis. 67, 481\u2013488 (2019).","journal-title":"J. Alzheimers Dis."},{"key":"565_CR38","doi-asserted-by":"publisher","first-page":"263","DOI":"10.1136\/jnnp-2019-321954","volume":"91","author":"C Heller","year":"2020","unstructured":"Heller, C. et al. Plasma glial fibrillary acidic protein is raised in progranulin-associated frontotemporal dementia. J. Neurol. Neurosurg. Psychiatry 91, 263\u2013270 (2020).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"565_CR39","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1186\/s13195-020-00682-7","volume":"12","author":"IMW Verberk","year":"2020","unstructured":"Verberk, I. M. W. et al. Combination of plasma amyloid beta(1-42\/1-40) and glial fibrillary acidic protein strongly associates with cerebral amyloid pathology. Alzheimers Res. Ther. 12, 118 (2020).","journal-title":"Alzheimers Res. Ther."},{"key":"565_CR40","doi-asserted-by":"publisher","first-page":"1065","DOI":"10.1002\/ana.25874","volume":"88","author":"KB Rajan","year":"2020","unstructured":"Rajan, K. B. et al. Remote blood biomarkers of longitudinal cognitive outcomes in a population study. Ann. Neurol. 88, 1065\u20131076 (2020).","journal-title":"Ann. Neurol."},{"key":"565_CR41","doi-asserted-by":"publisher","first-page":"1305","DOI":"10.1136\/jnnp-2021-326487","volume":"92","author":"K Katisko","year":"2021","unstructured":"Katisko, K. et al. GFAP as a biomarker in frontotemporal dementia and primary psychiatric disorders: diagnostic and prognostic performance. J. Neurol. Neurosurg. Psychiatry 92, 1305\u20131312 (2021).","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"565_CR42","doi-asserted-by":"publisher","first-page":"2586","DOI":"10.1161\/STROKEAHA.117.018409","volume":"48","author":"AH Katsanos","year":"2017","unstructured":"Katsanos, A. H. et al. Plasma glial fibrillary acidic protein in the differential diagnosis of intracerebral hemorrhage. Stroke 48, 2586\u20132588 (2017).","journal-title":"Stroke"},{"key":"565_CR43","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1007\/s00415-009-0054-8","volume":"256","author":"J Und\u00e9n","year":"2009","unstructured":"Und\u00e9n, J. et al. Explorative investigation of biomarkers of brain damage and coagulation system activation in clinical stroke differentiation. J. Neurol. 256, 72\u201377 (2009).","journal-title":"J. Neurol."},{"key":"565_CR44","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/j.jalz.2019.09.004","volume":"16","author":"FM Elahi","year":"2020","unstructured":"Elahi, F. M. et al. Plasma biomarkers of astrocytic and neuronal dysfunction in early- and late-onset Alzheimer\u2019s disease. Alzheimers Dement. 16, 681\u2013695 (2020).","journal-title":"Alzheimers Dement."},{"key":"565_CR45","doi-asserted-by":"publisher","first-page":"e12291","DOI":"10.1002\/dad2.12291","volume":"14","author":"D Shir","year":"2022","unstructured":"Shir, D. et al. Association of plasma glial fibrillary acidic protein (GFAP) with neuroimaging of Alzheimer\u2019s disease and vascular pathology. Alzheimers Dement. (Amst.) 14, e12291 (2022).","journal-title":"Alzheimers Dement. (Amst.)"},{"key":"565_CR46","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1056\/NEJMoa022066","volume":"348","author":"SE Vermeer","year":"2003","unstructured":"Vermeer, S. E. et al. Silent brain infarcts and the risk of dementia and cognitive decline. N. Engl. J. Med. 348, 1215\u20131222 (2003).","journal-title":"N. Engl. J. Med."},{"key":"565_CR47","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1038\/nrneurol.2015.10","volume":"11","author":"ND Prins","year":"2015","unstructured":"Prins, N. D. & Scheltens, P. White matter hyperintensities, cognitive impairment and dementia: an update. Nat. Rev. Neurol. 11, 157\u2013165 (2015).","journal-title":"Nat. Rev. Neurol."},{"key":"565_CR48","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-021-23746-0","volume":"12","author":"NC Cullen","year":"2021","unstructured":"Cullen, N. C. et al. Plasma biomarkers of Alzheimer\u2019s disease improve prediction of cognitive decline in cognitively unimpaired elderly populations. Nat. Commun. 12, 3555 (2021).","journal-title":"Nat. Commun."},{"key":"565_CR49","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1038\/s41582-019-0265-2","volume":"15","author":"I Fyfe","year":"2019","unstructured":"Fyfe, I. Neurofilament light chain \u2013 new potential for prediction and prognosis. Nat. Rev. Neurol. 15, 557 (2019).","journal-title":"Nat. Rev. Neurol."},{"key":"565_CR50","doi-asserted-by":"publisher","first-page":"913","DOI":"10.3233\/JAD-210342","volume":"82","author":"A Pilotto","year":"2021","unstructured":"Pilotto, A. et al. Plasma neurofilament light chain predicts cognitive progression in prodromal and clinical dementia with Lewy bodies. J. Alzheimers Dis. 82, 913\u2013919 (2021).","journal-title":"J. Alzheimers Dis."},{"key":"565_CR51","doi-asserted-by":"publisher","first-page":"135","DOI":"10.1016\/j.ebiom.2015.11.036","volume":"3","author":"M Gissl\u00e9n","year":"2016","unstructured":"Gissl\u00e9n, M. et al. Plasma concentration of the neurofilament light protein (NFL) is a biomarker of CNS injury in HIV infection: a cross-sectional study. EBioMedicine 3, 135\u2013140 (2016).","journal-title":"EBioMedicine"},{"key":"565_CR52","doi-asserted-by":"publisher","first-page":"e4566","DOI":"10.1097\/MD.0000000000004566","volume":"95","author":"YL Chai","year":"2016","unstructured":"Chai, Y. L. et al. Growth differentiation factor-15 and white matter hyperintensities in cognitive impairment and dementia. Medicine (Baltimore) 95, e4566 (2016).","journal-title":"Medicine (Baltimore)"},{"key":"565_CR53","doi-asserted-by":"publisher","first-page":"eadf5681","DOI":"10.1126\/scitranslmed.adf5681","volume":"15","author":"KA Walker","year":"2023","unstructured":"Walker, K. A. et al. Proteomics analysis of plasma from middle-aged adults identifies protein markers of dementia risk in later life. Sci. Transl. Med. 15, eadf5681 (2023).","journal-title":"Sci. Transl. Med."},{"key":"565_CR54","doi-asserted-by":"publisher","first-page":"399","DOI":"10.1007\/s00441-010-1090-5","volume":"343","author":"K Schindowski","year":"2011","unstructured":"Schindowski, K. et al. Regulation of GDF-15, a distant TGF-\u03b2 superfamily member, in a mouse model of cerebral ischemia. Cell Tissue Res. 343, 399\u2013409 (2011).","journal-title":"Cell Tissue Res."},{"key":"565_CR55","doi-asserted-by":"publisher","first-page":"2568","DOI":"10.1161\/STROKEAHA.115.009026","volume":"46","author":"C Andersson","year":"2015","unstructured":"Andersson, C. et al. Associations of circulating growth differentiation factor-15 and ST2 concentrations with subclinical vascular brain injury and incident stroke. Stroke 46, 2568\u20132575 (2015).","journal-title":"Stroke"},{"key":"565_CR56","doi-asserted-by":"publisher","first-page":"2712","DOI":"10.1161\/STROKEAHA.107.513176","volume":"39","author":"EJ van Dijk","year":"2008","unstructured":"van Dijk, E. J. et al. Progression of cerebral small vessel disease in relation to risk factors and cognitive consequences: Rotterdam Scan study. Stroke 39, 2712\u20132719 (2008).","journal-title":"Stroke"},{"key":"565_CR57","doi-asserted-by":"publisher","first-page":"101569","DOI":"10.1016\/j.arr.2022.101569","volume":"75","author":"M Conte","year":"2022","unstructured":"Conte, M. et al. GDF15, an emerging key player in human aging. Ageing Res. Rev. 75, 101569 (2022).","journal-title":"Ageing Res. Rev."},{"key":"565_CR58","doi-asserted-by":"publisher","first-page":"592","DOI":"10.1038\/s41574-021-00529-7","volume":"17","author":"D Wang","year":"2021","unstructured":"Wang, D. et al. GDF15: emerging biology and therapeutic applications for obesity and cardiometabolic disease. Nat. Rev. Endocrinol. 17, 592\u2013607 (2021).","journal-title":"Nat. Rev. Endocrinol."},{"key":"565_CR59","doi-asserted-by":"publisher","first-page":"199","DOI":"10.1186\/s13195-021-00944-y","volume":"13","author":"JD Marks","year":"2021","unstructured":"Marks, J. D. et al. Comparison of plasma neurofilament light and total tau as neurodegeneration markers: associations with cognitive and neuroimaging outcomes. Alzheimers Res. Ther. 13, 199 (2021).","journal-title":"Alzheimers Res. Ther."},{"key":"565_CR60","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1002\/alz.12233","volume":"17","author":"KAQ Cousins","year":"2021","unstructured":"Cousins, K. A. Q. et al. ATN incorporating cerebrospinal fluid neurofilament light chain detects frontotemporal lobar degeneration. Alzheimers Dement. 17, 822\u2013830 (2021).","journal-title":"Alzheimers Dement."},{"key":"565_CR61","doi-asserted-by":"publisher","first-page":"e671","DOI":"10.1212\/WNL.0000000000011226","volume":"96","author":"I Ill\u00e1n-Gala","year":"2021","unstructured":"Ill\u00e1n-Gala, I. et al. Plasma tau and neurofilament light in frontotemporal lobar degeneration and Alzheimer disease. Neurology 96, e671\u2013e683 (2021).","journal-title":"Neurology"},{"key":"565_CR62","doi-asserted-by":"publisher","first-page":"88","DOI":"10.1002\/alz.12369","volume":"18","author":"Y Jiang","year":"2022","unstructured":"Jiang, Y. et al. Large-scale plasma proteomic profiling identifies a high-performance biomarker panel for Alzheimer\u2019s disease screening and staging. Alzheimers Dement. 18, 88\u2013102 (2022).","journal-title":"Alzheimers Dement."},{"key":"565_CR63","unstructured":"Prince, M. et al. World Alzheimer Report 2015\u2014The Global Impact of Dementia: An Analysis of Prevalence, Incidence, Cost and Trends. Alzheimer\u2019s Disease International www.alzint.org\/resource\/world-alzheimer-report-2015\/ (2015)."},{"key":"565_CR64","doi-asserted-by":"publisher","first-page":"101665","DOI":"10.1016\/j.eclinm.2022.101665","volume":"53","author":"J You","year":"2022","unstructured":"You, J. et al. Development of a novel dementia risk prediction model in the general population: a large, longitudinal, population-based machine-learning study. EClinicalMedicine 53, 101665 (2022).","journal-title":"EClinicalMedicine"},{"key":"565_CR65","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1038\/s41586-023-06592-6","volume":"622","author":"BB Sun","year":"2023","unstructured":"Sun, B. B. et al. Plasma proteomic associations with genetics and health in the UK Biobank. Nature 622, 329\u2013338 (2023).","journal-title":"Nature"},{"key":"565_CR66","doi-asserted-by":"publisher","first-page":"339","DOI":"10.1038\/s41586-023-06547-x","volume":"622","author":"RS Dhindsa","year":"2023","unstructured":"Dhindsa, R. S. et al. Rare variant associations with plasma protein levels in the UK Biobank. Nature 622, 339\u2013347 (2023).","journal-title":"Nature"},{"key":"565_CR67","doi-asserted-by":"publisher","first-page":"100168","DOI":"10.1016\/j.mcpro.2021.100168","volume":"20","author":"L Wik","year":"2021","unstructured":"Wik, L. et al. Proximity extension assay in combination with next-generation sequencing for high-throughput proteome-wide analysis. Mol. Cell Proteomics 20, 100168 (2021).","journal-title":"Mol. Cell Proteomics"},{"key":"565_CR68","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1093\/ije\/dym276","volume":"37","author":"P Elliott","year":"2008","unstructured":"Elliott, P., Peakman, T. C. & UK Biobank The UK Biobank sample handling and storage protocol for the collection, processing and archiving of human blood and urine. Int. J. Epidemiol. 37, 234\u2013244 (2008).","journal-title":"Int. J. Epidemiol."},{"key":"565_CR69","doi-asserted-by":"publisher","DOI":"10.1038\/s41467-023-43575-7","volume":"14","author":"J You","year":"2023","unstructured":"You, J. et al. Plasma proteomic profiles predict individual future health risk. Nat. Commun. 14, 7817 (2023).","journal-title":"Nat. Commun."},{"key":"565_CR70","doi-asserted-by":"publisher","first-page":"723","DOI":"10.1016\/j.jalz.2018.01.003","volume":"14","author":"J Tynkkynen","year":"2018","unstructured":"Tynkkynen, J. et al. Association of branched-chain amino acids and other circulating metabolites with risk of incident dementia and Alzheimer\u2019s disease: a prospective study in eight cohorts. Alzheimers Dement. 14, 723\u2013733 (2018).","journal-title":"Alzheimers Dement."},{"key":"565_CR71","doi-asserted-by":"publisher","first-page":"128","DOI":"10.1186\/1471-2105-14-128","volume":"14","author":"EY Chen","year":"2013","unstructured":"Chen, E. Y. et al. Enrichr: interactive and collaborative HTML5 gene list enrichment analysis tool. BMC Bioinformatics 14, 128 (2013).","journal-title":"BMC Bioinformatics"},{"key":"565_CR72","doi-asserted-by":"publisher","DOI":"10.1186\/s13059-019-1716-1","volume":"20","author":"K Korthauer","year":"2019","unstructured":"Korthauer, K. et al. A practical guide to methods controlling false discoveries in computational biology. Genome Biol. 20, 118 (2019).","journal-title":"Genome Biol."},{"key":"565_CR73","unstructured":"Guolin K. et al. LightGBM: a highly efficient gradient boosting decision tree. In Advances in Neural Information Processing Systems 30 (NIPS 2017) (eds von Luxburg, U., Guyon, I., Bengio, S., Wallach, H. & Fergus, R.) 3149\u20133157 (Curran Associates Inc., 2017)."},{"key":"565_CR74","doi-asserted-by":"publisher","first-page":"837","DOI":"10.2307\/2531595","volume":"44","author":"ER DeLong","year":"1988","unstructured":"DeLong, E. R., DeLong, D. M. & Clarke-Pearson, D. L. Comparing the areas under two or more correlated receiver operating characteristic curves: a nonparametric approach. Biometrics 44, 837\u2013845 (1988).","journal-title":"Biometrics"},{"key":"565_CR75","doi-asserted-by":"publisher","first-page":"77","DOI":"10.1186\/1471-2105-12-77","volume":"12","author":"X Robin","year":"2011","unstructured":"Robin, X. et al. pROC: an open-source package for R and S+ to analyze and compare ROC curves. BMC Bioinformatics 12, 77 (2011).","journal-title":"BMC Bioinformatics"},{"key":"565_CR76","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1161\/CIRCRESAHA.119.314929","volume":"125","author":"F Fang","year":"2019","unstructured":"Fang, F. et al. Lipids, apolipoproteins, and the risk of Parkinson disease. Circ. Res. 125, 643\u2013652 (2019).","journal-title":"Circ. Res."}],"container-title":["Nature Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s43587-023-00565-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-023-00565-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s43587-023-00565-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T08:05:14Z","timestamp":1708416314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s43587-023-00565-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,2,12]]},"references-count":76,"journal-issue":{"issue":"2","published-online":{"date-parts":[[2024,2]]}},"alternative-id":["565"],"URL":"https:\/\/doi.org\/10.1038\/s43587-023-00565-0","relation":{},"ISSN":["2662-8465"],"issn-type":[{"value":"2662-8465","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,2,12]]},"assertion":[{"value":"9 June 2023","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"22 December 2023","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"12 February 2024","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}